Mexico's President Claudia Sheinbaum says she sent a letter to Google asking the company not to comply with President Donald Trump's order to change the name of the Gulf of Mexico to the Gulf of ...
President Donald Trump on Saturday imposed tariffs on imports from Canada, Mexico and China, the nation’s three largest trading partners, invoking emergency economic powers in a high-stakes bid ...
Boarding the flight to Cabo with my husband, Alejandro, my arms felt unnervingly light. It was our first trip without Ona, our five-month-old daughter. “She’ll be fine,” my mother-in-law had ...
Mexico has the 15th largest nominal gross domestic product (GDP) in the world and its economic improvement has been linked primarily to its involvement with the North American Free Trade Agreement ...
A ranking of the top songs based on streaming and sales activity from within the country- as tracked by Luminate. The ranking is based on a weighted formula incorporating official-only streams ...
The passenger list included four crew members, a pediatric patient and a family member, according to a statement from Jet Rescue Air Ambulance, the Mexico-based air ambulance company coordinating the ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
An FDA recall on chocolate-covered fruit and nuts sold in Ohio and elsewhere has been upgraded to the most serious classification due to an undeclared allergen, according to media reports. In December ...
Rybelsus (semaglutide) is the first GLP-1 agonist drug that can be dosed orally, and is Novo Nordisk's third drug in the class after daily injectable Victoza (liraglutide) and weekly shot Ozempic ...
Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat people with type 2 diabetes. The drugs, classified as GLP-1 agonists, have also been used for weight loss in ...
Industry reports estimate that India's medical tourism market was valued at $7.69 billion in 2024, with approximately 7.3 million foreign patients travelling to India for medical treatment ...